Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of study drug (BMS-820836) as compared
with continued Duloxetine/Escitalopram in the treatment of patients with treatment resistant
depression (TRD).